Approval · Notice of Compliance 29218 · 2022
KERENDIA: Notice of Compliance 29218
Issued October 14, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29218
- Date
- October 14, 2022
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- FINERENONE 10 MG per TAB
- FINERENONE 20 MG per TAB